Page last updated: 2024-08-26

arginine methyl ester and icatibant

arginine methyl ester has been researched along with icatibant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frohlich, ED; Nakamura, Y; Ono, H; Zhou, X	1

Other Studies

1 other study(ies) available for arginine methyl ester and icatibant

Article	Year
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:5 Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Body Weight; Bradykinin; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Organ Size; Protective Agents; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2001

Article

Year

Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.

Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:5

Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Body Weight; Bradykinin; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Organ Size; Protective Agents; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2001